Geriatric annual exam checklist SEO Brief & AI Prompts

A geriatric annual exam is a structured primary-care visit that combines frailty screening, falls prevention assessment, and a stepwise polypharmacy review; core components include a brief gait-speed or Timed Up and Go test, a Clinical Frailty Scale score, and medication reconciliation for patients taking five or more chronic medications. The first-line measurements are gait speed (≤0.8 m/s suggests reduced reserve), Timed Up and Go (TUG >12 seconds indicates elevated fall risk), and Clinical Frailty Scale (CFS ≥5 denotes frailty). Documentation should record these numeric results, current medication count, and advance care preferences to guide management. A brief cognitive screen (Mini-Cog) and advance care planning review are often included.

Mechanistically, combining physical performance measures and medication review identifies reduced physiologic reserve and modifiable contributors to adverse outcomes: the Timed Up and Go and gait speed quantify mobility while the Clinical Frailty Scale captures multi-domain vulnerability, and medication reconciliation exposes potentially inappropriate drugs using Beers criteria or STOPP/START lists. A polypharmacy review focused on indications, adverse effects, and drug–drug interactions reduces iatrogenic contributors to falls and cognitive decline. For point-of-care workflows, short validated tools (TUG, 3-meter gait) and structured EHR templates expedite screening, while linking results to referrals for physical therapy, occupational therapy, or pharmacist-led deprescribing supports implementation. Local protocols can assign roles to nurses, pharmacists, and PTs.

A key nuance is that chronological age alone is an unreliable trigger for testing; functional status and frailty phenotype drive decision-making. For example, an ambulatory 85-year-old with gait speed 1.0 m/s and CFS 2 may need routine preventive care, while a 70-year-old with gait speed 0.6 m/s, TUG 16 seconds, and CFS 5 requires intensified fall-risk management and targeted deprescribing. Polypharmacy review must move beyond counting medications to a stepwise process: medication reconciliation, indication verification, risk–benefit assessment using Beers criteria and STOPP/START, development of taper plans, and scheduled follow-up to monitor withdrawal effects and symptom recurrence. Clinicians should avoid age-based exclusion and document CFS, TUG, gait speed, and medication reconciliation, triggering pharmacist review when medication count is five or more and adding orthostatic vitals. Home-safety assessments frequently alter recommendations significantly.

Practical steps include recording a timed gait or TUG, assigning a CFS score, performing medication reconciliation with STOPP/START and Beers criteria in mind, and documenting follow-up plans for tapering high-risk agents; these measures can be integrated into a brief EHR template and scheduled 30- to 45-minute annual-visit workflows. Clinics that track numeric thresholds (gait ≤0.8 m/s, TUG >12 s, CFS ≥5, medication count ≥5) can prioritize referrals to PT, OT, or pharmacist-led deprescribing. Templates, patient handouts, and practical billing tips support clinic adoption. This page contains a structured, step-by-step framework for point-of-care implementation.